Ultrasound Technology Enhances Safety in Cosmetic Filler Procedures
Every year, over 5 million cosmetic filler procedures take place in the U.S., but these injectables can dangerously block blood vessels, posing significant risks to patients. A recent study shared at the Radiological Society of North America (RSNA) annual meeting highlighted that ultrasound technology can identify these hazardous blockages early, directing treatment and potentially preventing long-term damage.
The research involved data from 100 patients across six locations who faced vascular complications following hyaluronic acid filler injections, with information collected from May 2022 to April 2025.
This study sheds light on a rare neck condition that could make routine salon hair washing a serious risk for strokes.
The findings suggested that ultrasound effectively detected vascular occlusions, or blockages, halting proper blood flow. If left untreated, this condition could lead to pain, damage to the skin, scarring, and in severe situations, vision loss or strokes.
“Doppler ultrasound allows doctors to accurately visualize filler locations and monitor blood flow in real time, enabling them to assess whether blood vessels have been impacted after cosmetic treatments,” explained lead researcher Rosa Maria Silveira Sigrist, M.D., a senior radiologist at the University of São Paulo in Brazil.
“Physical exams are still crucial, but ultrasound provides additional insights, enhancing evaluation safety and treatment accuracy.”
The study revealed that over 40% of patients had blockages in smaller connecting blood vessels, known as perforators, while 35% experienced complete blood flow loss in significant facial arteries. The nasal area was particularly vulnerable since the lateral nasal artery, which runs alongside the nose, supplies blood to key arteries going to the eyes and brain.
“Vessel occlusions following filler injections can lead to severe outcomes like skin necrosis and tissue loss, with worst-case scenarios including blindness and stroke,” commented Dr. Anthony Barrett, a board-certified plastic surgeon in New Jersey not associated with the study. “Occlusions in vital arteries, especially those feeding the retina and skin, can cause irreversible damage.”
Dr. Samuel Golpanian, a dual board-certified plastic surgeon in Beverly Hills, said that with a skilled and qualified professional using proper techniques, the risk of vascular occlusion should be below 1 percent. However, in procedures carried out by untrained individuals or with improper methods, the complication rate might increase to between 10% and 20%, which is quite alarming.
Ultrasound aids doctors in locating blockages, allowing for the precise application of lytic enzymes (hyaluronidase) as needed, which minimizes guesswork and reduces the likelihood of administering excessive doses. The researchers proposed that conducting ultrasound during the actual injection process could prevent injuries to blood vessels and enable quicker, more accurate responses if an obstruction arises.
Dr. Asif Pilani, a board-certified cosmetic plastic surgeon in Toronto, Canada, emphasized the value of integrating ultrasound into treatment workflows to support timely decisions. He pointed out that this could either happen as a point-of-care tool in trained hands or be utilized post-initial rescue therapy.
To reduce serious complications, Pirano, an external expert not involved in the research, stressed the importance of ensuring that injectable treatments are administered by board-certified specialists familiar with facial anatomy and complication management protocols.
Research Limitations
Among the study’s limitations are the relatively small sample size of 100 adults and that it has yet to undergo peer review. The lead researcher mentioned, “Even skilled professionals can differ in how they perform Doppler tests, highlighting the need for standardized guidelines to ensure more consistent trial execution.”
Notably, all participants experienced significant complications, meaning the results may not be applicable to individuals facing milder issues or those who use different types of fillers. Moreover, since the study took place in Brazil, geographical bias may exist, as training standards can differ from those in the U.S.
The study suggests that future research should involve monitoring a broader group of patients over time and examining their recovery following ultrasound-guided treatments.
